The U.S. Food and Drug Administration (FDA) sent a letter to cardiologists this week to explain its evaluation of...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
The Abiomed Impella RP had higher than expected mortality in its post-approval study, much higher than in its pre-market approval study. The vendor and the FDA believe this might be due to poor patient selection and implanting the device too late to aid the patient.
Feature | Hemodynamic Support Devices | February 05, 2019 | Dave Fornell, Editor
Technology | Angiography | February 04, 2019
February 4, 2019 — Canon Medical Systems USA recently introduced its next generation of...
Two of the top news items from January included news atrial fibrillation guidelines that now recommend new anticoagulants (NOACs) over warfarin, and the FDA warning hospitals about the increased mortality found in one study involving pacitaxel-eluting stents and balloon devices for the peripheral arteries.
Feature | February 01, 2019 | Dave Fornell, Editor
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (...
Technology | Hemostasis Management | February 01, 2019
February 1, 2019 — Merit Medical Systems Inc. announced that the PreludeSync Distal Compression Device is now...
News | Catheters | January 31, 2019
January 31, 2019 — Cardiovascular Systems Inc. announced that the first patients in the United States were treated...
A view of GE Healthcare's volume max, or Vmax, which allows for nearly triple the frame rate speeds on 3-D TEE in a single beat over previous-generation systems.
Feature | Cardiovascular Ultrasound | January 31, 2019 | Dave Fornell, Editor
The higher expense and lower frame rates of 3-D...
A macrophage immune cell, with a dead cell (pink) that has been eaten, and a mitochondrion (green) between the dead cell and the nucleus. The study’s findings indicate that what the macrophage eats is taken up by the mitochondrion, which in turn communicates with the nucleus to activate the macrophage to promote tissue repair. Image courtesy of Northwestern Medicine.
News | Cath Lab | January 30, 2019
January 30, 2019 — Northwestern Medicine scientists have discovered a novel signaling pathway that promotes healing...
The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.
Feature | Peripheral Artery Disease (PAD) | January 30, 2019 | Dave Fornell, Editor
In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat...
Technology | Chronic Total Occlusion (CTO) | January 30, 2019
January 30, 2019 — XableCath Inc., announced that its XableCath blunt and abrasion tip catheters were cleared by the...
News | Heart Valve Technology | January 29, 2019
January 29, 2019 — Thubrikar Aortic Valve Inc. announced the first human implant of the Optimum TAV using their...
The Medtronic Resolute Integrity drug-eluting stent (DES) is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data.
Feature | Stents | January 29, 2019 | Dave Fornell, Editor
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years...
An example of multimodality image fusion with live angiography to enhance soft-tissue visualization during complex procedures. This example is from Siemen's new TrueFusion software released in 2018.
Feature | Angiography | January 28, 2019 | Dave Fornell, Editor
There are a few recent trends in X-ray...
News | Heart Valve Technology | January 28, 2019
January 28, 2019 — Lenox Hill Hospital is the first hospital in New York City to successfully implant Abbott’s...
News | Drug-Eluting Balloons | January 28, 2019
January 28, 2019 — Philips announced the latest pooled analysis of patient-level data of over 2,300 patients treated...
The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.
Feature | Peripheral Artery Disease (PAD) | January 25, 2019 | Dave Fornell, Editor
The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since...
